Glaxosmithkline Share News (GSK)

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock indexes were down on Monday. The Dow Jones industrialaverage was down 0.76 percent at 16,333.98, the S&P 500 was down 0.96 percent at 1,952.06 and the NasdaqComposite was down 0.92 percent at 4,662.53.

For a Breakingviews column, Investors' self-doubt worsensequity woes

** APPLE INC, $108.0301, +2.15 pct

The iPhone maker's shares rebounded sharply off day's lows,helping U.S. stocks stage a dramatic recovery. The shares openedmore than 10 percent lower in heavy trading. Stock still off afifth from February's record high.

For a Breakingviews column, Tech's real China syndromevictims are yet to fall

** BANK OF AMERICA CORP, $15.96, -0.87 pct

** CITIGROUP INC, $52.42, -2.20 pct

** MORGAN STANLEY, $33.47, -2.16 pct

** JPMORGAN CHASE & CO, $62.78, -1.29 pct

** GOLDMAN SACHS GROUP INC, $186.43, -0.70 pct

** WELLS FARGO & CO, $53.05, -1.70 pct

U.S. bank stocks continued to slide after last week's Fedminutes suggested the central bank may not raise interest ratesin September due to international developments, including weakeryuan.

Traders now see a 24 percent chance that Fed will increaserates in September, down from 30 percent late on Friday and 46percent a week earlier, according to Tullett Prebon data.

** NETFLIX INC, $106.57, +2.51 pct

** GENERAL MOTORS CO, $28.77, -2.80 pct

** TESLA MOTORS INC, $229.73, -0.45 pct

** CATERPILLAR INC, $74.67, -0.44 pct

** UNITED STATES STEEL CORP, $16.09, +1.13 pct

** ALCOA INC, $8.53, -2.29 pct

** YUM BRANDS, $78.61, -1.37 pct

Shares of U.S. companies fell at the open on China worries,though a handful of tech stocks were fighting against thebroadly weak market.

** SOLARCITY, $46.8701, +14.35 pct

** SUNEDISON INC, $11.61, +8.30 pct

The stocks snapped back from sharp plunges, with SolarCityup 11.5 percent after being down 15 percent in early trading.The relief rally comes one day after hedge fund manager JimChanos of Kynikos Associates said he was "short SolarCityshares" and criticized both companies' business models.

** ALIBABA GROUP HOLDING LTD, $66.92, -1.85 pct

** JD.COM INC, $24.765, -1.14 pct

** BAIDU INC, $144.395, -5.57 pct

** SINA CORP, $35.28, -2.65 pct

** YOUKU TUDOU, $16.18, -3.75 pct

** YY INC, $54.96, -7.19 pct

** CHINA DANGDANG, $6.3, -4.83 pct

** JUMEI INTERNATIONAL HOLDING, $10.78, -8.33 pct

U.S.-listed shares of Chinese technology companies fellafter Chinese indexes post their biggest one-day percentagelosses since the height of the financial crisis.

** EXXON MOBIL CORP, $70.82, -1.82 pct

** CONOCOPHILLIPS, $44.77, -1.37 pct

** CHEVRON CORP, $74.94, -1.08 pct

Oil prices fell more than 6 percent to fresh 6-1/2-year lowsas markets worried about a China-led global economic slowdownthat would drastically hit oil consumption at a time ofplentiful supply.

S&P 500 oil & gas, oilfield services companies havealready lost about $310 billion in market value this year.

For a Breakingviews column, Oil has room to get even moreirrational

** GLAXOSMITHKLINE PLC, $1,270.53703, -3.21 pct

** MERCK & CO, $54.81, -1.72 pct

** JOHNSON & JOHNSON, $95, -0.59 pct

** BIOGEN INC, $294.82, -0.28 pct

** CELGENE CORP, $118.59, -0.39 pct

** ELI LILLY & CO, $82.76, -2.09 pct

** BRISTOL-MYERS SQUIBB CO, $60.88, -0.31 pct

** PFIZER INC, $33.21 -0.98 pct

** AMGEN INC, $153.58 -1.04 pct

** GILEAD SCIENCES INC, $106.08 +0.71 pct

The S&P 500 Healthcare sector index declined 3percent to 801.97, Nasdaq Biotechnology index down nearly4 percent at 3436.71

** OCATA THERAPEUTICS INC, $4.5816 +20.25 pct

The drug developer awarded Small Business InnovationResearch grant from National Institute of Allergy and InfectiousDiseases, part of National Institutes of Health.

** EPIZYME INC, $18.9 +18.64 pct

The drug developer said U.S. Food and Drug Administrationaccepted its application to start clinical studies of its leadcancer drug, Tazemetostat.

** HMS HOLDINGS CORP, $10.73 +21.38 pct

The New York State Office of the Medicaid Inspector Generalawarded the healthcare facility provider a contract for Medicaidthird-party liability match and recovery services.

** HUBBELL INC, $113.25 +22.68 pct

The electrical equipment maker said it plans to reclassifycommon stock to eliminate its existing two-class structure.

** GEVO INC, $2.54 +10.92 pct

The chemical maker and Butamax Advanced Biofuels LLC, ajoint venture between BP and DuPont, ended apatent dispute related to the production of bio-based fueladditive, isobutanol, and entered into cross-license andsettlement agreements.

** ABERCROMBIE & FITCH CO, $17.58 +6.87 pct

Piper Jaffray upgrades the apparel retailer's stock to"overweight" from "neutral" and raises price target by $2 to$27.

** AGL RESOURCES INC, $62.01, +29.57 pct

** SOUTHERN CO, $44.58, -2.66 pct

Power producer Southern said it would buy AGL Resources forabout $8 billion in cash to become the No. 2 U.S. utility bycustomers after Exelon Corp.

** VITAL THERAPIES INC, $4.02, -77.26 pct

The drug developer said it would stop two ongoing trialstesting its cell-therapy, ELAD, after it failed a late-stagestudy in liver failure patients.

** CHINACACHE INTERNATIONAL HOLDINGS LTD, $6.02,+7.69 pct

The China-based network service provider plans to buy backup to $6 million worth of outstanding ADSs over the next 12months. This is in addition to ChinaCache's existing $10 millionshare buyback.

** EXELIXIS INC, $5.455, +3.90 pct

The U.S. FDA granted the drugmaker's lead drug,cabozantinib, "breakthrough therapy" status to treat patientswith the most common form of kidney cancer.

(Compiled by Arunima Banerjee in Bengaluru; Editing by SrirajKalluvila)